Literature DB >> 14976189

The CD20 calcium channel is localized to microvilli and constitutively associated with membrane rafts: antibody binding increases the affinity of the association through an epitope-dependent cross-linking-independent mechanism.

Haidong Li1, Linda M Ayer, Maria J Polyak, Cathlin M Mutch, Ryan J Petrie, Laura Gauthier, Neda Shariat, Michael J Hendzel, Andrew R Shaw, Kamala D Patel, Julie P Deans.   

Abstract

CD20 is a B cell-specific membrane protein that functions in store-operated calcium entry and serves as a useful target for antibody-mediated therapeutic depletion of B cells. Antibody binding to CD20 induces a diversity of biological effects, some of which are dependent on lipid rafts. Rafts are isolated as low density detergent-resistant membranes, initially characterized using Triton X-100. We have previously reported that CD20 is soluble in 1% Triton but that antibodies induce the association of CD20 with Triton-resistant rafts. However, by using several other detergents to isolate rafts and by microscopic co-localization with a glycosylphosphatidylinositol-linked protein, we show in this report that CD20 is constitutively raft-associated. CD20 was distributed in a punctate pattern on the cell surface as visualized by fluorescence imaging and was also localized to microvilli by electron microscopy. The mechanism underlying antibody-induced association of CD20 with Triton-resistant rafts was investigated and found not to require cellular ATP, kinase activity, actin polymerization, or antibody cross-linking but was dependent on the epitope recognized. Thus, antibody-induced insolubility in 1% Triton most likely reflects a transition from relatively weak to strong raft association that occurs as a result of a conformational change in the CD20 protein.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976189     DOI: 10.1074/jbc.M400525200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis.

Authors:  E Janas; R Priest; J I Wilde; J H White; R Malhotra
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

2.  Cholesterol depletion inhibits src family kinase-dependent calcium mobilization and apoptosis induced by rituximab crosslinking.

Authors:  Tammy L Unruh; Haidong Li; Cathlin M Mutch; Neda Shariat; Lana Grigoriou; Ratna Sanyal; Christopher B Brown; Julie P Deans
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

3.  Patterns of expression, membrane localization, and effects of ectopic expression suggest a function for MS4a4B, a CD20 homolog in Th1 T cells.

Authors:  Hui Xu; Mark S Williams; Lisa M Spain
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

4.  Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain.

Authors:  Andrew T Vaughan; Claude H T Chan; Christian Klein; Martin J Glennie; Stephen A Beers; Mark S Cragg
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

5.  STIM1 knock-down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton-soluble membrane.

Authors:  W Heo; N Jin; M S Park; H-Y Kim; S M Yoon; J Lee; J Y Kim
Journal:  Clin Exp Immunol       Date:  2020-02-21       Impact factor: 4.330

Review 6.  CD20+ T cells: an emerging T cell subset in human pathology.

Authors:  Adrian Y S Lee
Journal:  Inflamm Res       Date:  2022-08-11       Impact factor: 6.986

7.  A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.

Authors:  Mariam Hammadi; Jacques-Olivier Pers; Christian Berthou; Pierre Youinou; Anne Bordron
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

8.  Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells.

Authors:  Andrei Ivanov; Stephen A Beers; Claire A Walshe; Jamie Honeychurch; Waleed Alduaij; Kerry L Cox; Kathleen N Potter; Stephen Murray; Claude H T Chan; Tetyana Klymenko; Jekaterina Erenpreisa; Martin J Glennie; Tim M Illidge; Mark S Cragg
Journal:  J Clin Invest       Date:  2009-07-20       Impact factor: 14.808

9.  Neurotrophin signaling through tropomyosin receptor kinases contributes to survival and proliferation of non-Hodgkin lymphoma.

Authors:  Lynn F Sniderhan; Tatiana M Garcia-Bates; Michael Burgart; Steven H Bernstein; Richard P Phipps; Sanjay B Maggirwar
Journal:  Exp Hematol       Date:  2009-08-28       Impact factor: 3.084

10.  Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.

Authors:  Zhengxing Qu; David M Goldenberg; Thomas M Cardillo; Victoria Shi; Hans J Hansen; Chien-Hsing Chang
Journal:  Blood       Date:  2007-11-19       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.